NorthWest Biotherapeutics Inc (NWBO)

[Schnauzer1]

To make the issue clear for you (rather than clouding the issue with the cranial), L was not created for the brain. It is a lysate method of activating D cells that is intended for all operable tumors. The idea is that the tumor is operated on and removed. So the L vaccine is intended to prevent re-occurrence (and manage residual amounts of tumor).

The reason NWBO picked GBM as a target is because of the easy of marketing due to the number of brain surgeons.

So the suggestion that the characteristics of L are special for the brain is a nonstarter.